Healthcare IT News May 11, 2020
Nathan Eddy

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “advanced discussions” to step down from the role, according to a Dow Jones report.

WHY IT MATTERS
Dr. Gawande, a surgeon and Harvard professor, was tapped to lead the then-unnamed joint venture nearly two years ago in 2018. Haven’s much-publicized debut positioned it as a disruptive force in the healthcare industry that would harness technology to lower costs...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Payer, Self-insured
UnitedHealth Vows to Reduce Prior Authorization Burden
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Insurer-PBM Firms Dominate Medicare Part D Market, Steering Patients to Their Pharmacies
Where did the private payers go?
Baystate's health plan sale collapses

Share This Article